Company / Free Cash Flow
CG Oncology, Inc. Free Cash Flow History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$132.5M
FY2025
5-year range
-$132.5M / -$78.9M
FY2024-FY2025
Trend
-67.8%
vs FY2024
Sector context
#124 of 195
Health Care
What the data says
At -$132M, CG Oncology, Inc.'s free cash flow ranks #124 of 195 in the Health Care sector.
Based on SEC 10-K filings.
-$132M in FY2025.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#124 of 195 in Health CareTop 64% of 195This company -$132.5M Sector average $467.5M
▼
-128.3% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 67.8% year-over-year.
- Ranks #124 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$132.5M | -67.8% |
| FY2024 | -$78.9M | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026